BioCentury
ARTICLE | Clinical News

Voclosporin regulatory update

April 13, 2017 3:46 PM UTC

Aurinia said it believes results from the planned Phase III AURORA trial and the completed Phase IIb AURA-LV trial of voclosporin will be sufficient for regulatory submissions of the product in the EU...

BCIQ Company Profiles

Aurinia Pharmaceuticals Inc.

BCIQ Target Profiles

Calcineurin